Evidence map›Paper›PMID 27325565›Full record

ArticleBioFactors (Oxford, England)2016

Pancreatic β-Cell production of CXCR3 ligands precedes diabetes onset.

Susan J Burke, Michael D Karlstad, Adrianna E Eder, Kellie M Regal, Danhong Lu, David H Burk, J Jason Collier

Abstract read
In one paragraph

Article in BioFactors (Oxford, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Chemokines in Gestational Diabetes Mellitus.Frontiers in immunology · 2022
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Genomewide Association Study Identifies Cxcl Family Members as Partial Mediators of LPS-Induced Periodontitis.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Susan J BurkeLaboratory of Islet Biology and Inflammation, Pennington Biomedical Research Center, Baton Rouge, LA, USA.
Michael D KarlstadDepartment of Surgery, Graduate School of Medicine, University of Tennessee Health Science Center, Knoxville, TN, USA.
Adrianna E EderDepartment of Surgery, Graduate School of Medicine, University of Tennessee Health Science Center, Knoxville, TN, USA.
Kellie M RegalDepartment of Surgery, Graduate School of Medicine, University of Tennessee Health Science Center, Knoxville, TN, USA.
Danhong LuSarah W. Stedman Nutrition and Metabolism Center, Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA.
David H BurkCell Biology and Bioimaging Core Facility, Pennington Biomedical Research Center, Baton Rouge, LA, USA.
J Jason CollierLaboratory of Islet Biology and Inflammation, Pennington Biomedical Research Center, Baton Rouge, LA, USA.ORCID http://orcid.org/0000-0003-2817-4152
Pennington Biomedical Research Center · USUniversity of Tennessee Health Science Center · USDuke University · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI JUDD E SHELLITO · 2012 to 2026
$69.1M
Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Sujoy Ghosh · 2005 to 2026
$26.5M
THE ROLE OF PROTEIN MALNUTRITION ON CIRCADIAN PHYSIOLOGY OF C57BL/6J MOUSE DAMSP20RR021945 · NCRR · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI GETTYS, THOMAS W · 2006 to 2011
$9.5M
Mentoring Obesity and Diabetes Research in LouisianaP20GM103528 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI GETTYS, THOMAS W · 2012 to 2015
$8.8M
Transgenics CoreP30GM118430 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI GETTYS, THOMAS W · 2016 to 2020
$5.8M
Development of an Atmospheric Plasma Applicator to Treat Chronic WoundsR44GM099207 · NIGMS · ADVANCED PLASMA PRODUCTS, INC. · PI JAMES, GARTH A, KARLSTAD, MICHAEL D · 2013 to 2014
$2.2M
NCRR NIH HHS P20 RR021945NIDDK NIH HHS P30 DK072476NIGMS NIH HHS P20 GM103528NIGMS NIH HHS P30 GM118430NIGMS NIH HHS R44 GM099207NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

Type 1 diabetes mellitus (T1DM) results from immune cell-mediated reductions in function and mass of the insulin-producing β-cells within the pancreatic islets. While the initial trigger(s) that initiates the autoimmune process is unknown, there is a leukocytic infiltration that precedes islet β-cell death and dysfunction. Herein, we demonstrate that genes encoding the chemokines CXCL9, 10, and 11 are primary response genes in pancreatic β-cells and are also elevated as part of the inflammatory response in mouse, rat, and human islets. We further established that STAT1 participates in the transcriptional control of these genes in response to the pro-inflammatory cytokines IL-1β and IFN-γ. STAT1 is phosphorylated within five minutes after β-cell exposure to IFN-γ, with subsequent occupancy at proximal and distal response elements within the Cxcl9 and Cxcl11 gene promoters. This increase in STAT1 binding is coupled to the rapid appearance of chemokine transcript. Moreover, circulating levels of chemokines that activate CXCR3 are elevated in non-obese diabetic (NOD) mice, consistent with clinical findings in human diabetes. We also report herein that mice with genetic deletion of CXCR3 (receptor for ligands CXCL9, 10, and 11) exhibit a delay in diabetes development after being injected with multiple low doses of streptozotocin. Therefore, we conclude that production of CXCL9, 10, and 11 from islet β-cells controls leukocyte migration and activity into pancreatic tissue, which ultimately influences islet β-cell mass and function. © 2016 BioFactors, 42(6):703-715, 2016.

Indexed as

AnimalsBlood GlucoseCell LineChemokine CXCL11Chemokine CXCL9Diabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1Disease ProgressionFemaleHumansHyperglycemiaInsulin-Secreting CellsJanus KinasesLigandsMaleMice, Inbred BALB CBlood GlucoseChemokine CXCL11Chemokine CXCL9Cxcl11 protein, mouseCxcl9 protein, mouseCxcr3 protein, mouseJanus KinasesLigandsReceptors, CXCR3Stat1 protein, mouseSTAT1 Transcription Factorautoimmunitychemokinediabetesinflammationisletstranscription

Identifiers

PMID27325565
PMCPMC5177512
OpenAlexW2474714634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.